Metraipolis › archive › dc_ebc3da5979fb

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS — Europe PMC PMID:41182765

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41182765
DOI: 10.1001/jamanetworkopen.2025.41025
License (as archived): solo-consultazione
Archived: 2026-11-08T20:20:49.354Z
SHA-256 of the archived text: 31ec95e32c6be37faeaa46f413802f4d065b7359f7e9d67d2c636a5855b2be9c
Stable URL of this page: https://metraipolis.com/documento/dc_ebc3da5979fb

How to cite

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS — Europe PMC PMID:41182765 — Europe PMC (en), https://europepmc.org/article/MED/41182765 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebc3da5979fb (Metraipolis archive dc_ebc3da5979fb, sha256 31ec95e32c6be37faeaa46f413802f4d065b7359f7e9d67d2c636a5855b2be9c)

BibTeX

@misc{dcebc3da5979fb,
  title = {Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS — Europe PMC PMID:41182765},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41182765},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebc3da5979fb; sha256 31ec95e32c6be37faeaa46f413802f4d065b7359f7e9d67d2c636a5855b2be9c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41182765. Agents can read the archived copy with the MCP tool read_document.